Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.3250
0.008002.52%
At close: -
$0.3055
-0.02-6.00%
After Hours: 7:23 PM EDT
Comments
Loading...
Bolt Biotherapeutics Stock Price, Quotes and Forecasts
BOLTNASDAQ
Bolt Biotherapeutics (BOLT) Forecast
NewsEarningsBolt Biotherapeutics (BOLT) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Bolt Biotherapeutics Stock Price, Quotes and Forecasts | NASDAQ:BOLT | Benzinga
Explore Bolt Biotherapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BOLT.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Bolt Biotherapeutics (BOLT) stock?
You can purchase shares of Bolt Biotherapeutics (NASDAQ:BOLT) through any online brokerage.
Who are Bolt Biotherapeutics (BOLT) competitors?
Other companies in Bolt Biotherapeutics’s space includes: Immuron (NASDAQ:IMRN), Acurx Pharmaceuticals (NASDAQ:ACXP), Cellectar Biosciences (NASDAQ:CLRB), Evaxion (NASDAQ:EVAX) and Can Fite Biofarma (AMEX:CANF).
What is the forecast, or price target, for Bolt Biotherapeutics (BOLT) stock?
Bolt Biotherapeutics has a consensus price target of $2.60.
What is the current price for Bolt Biotherapeutics (BOLT)?
The stock price for Bolt Biotherapeutics (NASDAQ: BOLT) is $0.3055 last updated May 22, 2025 at 7:23 PM EDT.
Does Bolt Biotherapeutics (BOLT) pay a dividend?
A quarterly cash dividend of 0.09 per share of Class A Common Stock. The quarterly cash dividend was payable on October 2, 2014 to stockholders of record on September 1, 2014.
When is Bolt Biotherapeutics (NASDAQ:BOLT) reporting earnings?
Bolt Biotherapeutics’s Q2 earnings are confirmed for Tuesday, August 12, 2025.
Is Bolt Biotherapeutics (BOLT) going to split?
There is no upcoming split for Bolt Biotherapeutics.
What sector and industry does Bolt Biotherapeutics (BOLT) operate in?
Bolt Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
